COMP <GO>
TCMD vs ANGO // ENTERPRISE SCALE & MARKET CAP
Tactile Systems Technology Inc. (NASDAQ) VS. AngioDynamics Inc. (NASDAQ) • 15-METRIC TALLY: TCMD 10
— ANGO 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TCMD
LAST: $22.87 (-0.74%) • MKT CAP: $521.9M
market-cap
$521.9M
LAST: $11.76 (-1.92%) • MKT CAP: $504.2M
market-cap
$504.2M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TCMD VS. ANGO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TCMD | ANGO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.90% | 54.60% | +21.30 | TCMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | -23.40% | +40.50 | TCMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | 0.10% | +7.24 | TCMD | /fcf-yield <GO> |
| Operating Margin | 8.90% | -12.50% | +21.40 | TCMD | /operating-margins <GO> |
| Net Profit Margin | 5.80% | -11.50% | +17.30 | TCMD | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | 9.50% | +3.00 | TCMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.38 | 2.12 | +6.26 | TCMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | TCMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.9 | 40.8 | +8.10 | TCMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $521.9M | $504.2M | $17.7M | TCMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TCMD REV | ANGO REV | TCMD GROSS % | ANGO GROSS % | TCMD FCF | ANGO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $329.5M | $320.2M | 75.9% | 54.6% | $40.4M | $508.0K |
| FY 2024 | $293.0M | $292.5M | 74.0% | 53.9% | $38.3M | -$14.6M |
| FY 2023 | $274.4M | $303.9M | — | — | $35.9M | -$28.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TCMD // BETA —
ANGO // BETA —